Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
Journal of the American Heart Association
|
April 19, 2024
Urinary Proteomics and Outcomes in Heart Failure With Preserved Ejection Fraction
Corinne Carland, Lei Zhao, Oday Salman, et al.
Circulation
|
April 25, 2024
SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy
Anna Kovilakath, Adolfo G Mauro, Yolander A Valentine, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 28, 2022
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial
Hiddo J L Heerspink, Remo H M Furtado, Otavio Berwanger, et al.
JACC. Advances
|
June 27, 2025
Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans
Carla Valenzuela Ripoll, Aynaz Lotfinaghsh, Zhen Guo, et al.
Journal of Critical Care
|
November 15, 2024
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19
Laurence W Busse, J Pedro Teixeira, Christopher L Schaich, et al.
Journal of the American Heart Association
|
February 29, 2024
Proteomic Associations of Adverse Outcomes in Human Heart Failure
Marie-Joe Dib, Michael G Levin, Lei Zhao, et al.
Med (New York, N.Y.)
|
November 29, 2023
Cardiac radiation improves ventricular function in mice and humans with cardiomyopathy
Lauren N Pedersen, Carla Valenzuela Ripoll, Mualla Ozcan, et al.
JACC. Basic to Translational Science
|
April 10, 2023
Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury
Zhen Guo, Carla Valenzuela Ripoll, Antonino Picataggi, et al.
Circulation
|
August 14, 2025
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy
Zhen Guo, Anahita Ataran, Pan Ma, et al.
The Lancet. Diabetes & Endocrinology
|
July 24, 2021
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
Mikhail N Kosiborod, Russell Esterline, Remo H M Furtado, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
Journal of the American Heart Association
|
April 19, 2024
Urinary Proteomics and Outcomes in Heart Failure With Preserved Ejection Fraction
Corinne Carland, Lei Zhao, Oday Salman, et al.
Circulation
|
April 25, 2024
SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy
Anna Kovilakath, Adolfo G Mauro, Yolander A Valentine, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 28, 2022
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial
Hiddo J L Heerspink, Remo H M Furtado, Otavio Berwanger, et al.
JACC. Advances
|
June 27, 2025
Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans
Carla Valenzuela Ripoll, Aynaz Lotfinaghsh, Zhen Guo, et al.
Journal of Critical Care
|
November 15, 2024
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19
Laurence W Busse, J Pedro Teixeira, Christopher L Schaich, et al.
Journal of the American Heart Association
|
February 29, 2024
Proteomic Associations of Adverse Outcomes in Human Heart Failure
Marie-Joe Dib, Michael G Levin, Lei Zhao, et al.
Med (New York, N.Y.)
|
November 29, 2023
Cardiac radiation improves ventricular function in mice and humans with cardiomyopathy
Lauren N Pedersen, Carla Valenzuela Ripoll, Mualla Ozcan, et al.
JACC. Basic to Translational Science
|
April 10, 2023
Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury
Zhen Guo, Carla Valenzuela Ripoll, Antonino Picataggi, et al.
Circulation
|
August 14, 2025
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy
Zhen Guo, Anahita Ataran, Pan Ma, et al.
The Lancet. Diabetes & Endocrinology
|
July 24, 2021
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
Mikhail N Kosiborod, Russell Esterline, Remo H M Furtado, et al.
Page
of 11